Abstract:Subsequently to the publication of the above article, an interested reader drew to the authors' attention that Fig. 2C and 2D apparently contained overlapping panels, suggesting that these data for purportedly different experiments had been derived from the same original source. The authors re‑examined their original data, and realized that the errors arose inadvertently during the process of compiling the figure. Essentially, multiple photographs of random fields in two directions per sample had been captured, and one photograph of the T24‑P group in a different direction was accidentally mis‑used for the T24‑L/siHIF‑1α group in Fig. 2C; another photograph of the T24‑P group in a different direction was accidentally mis‑used for the T24‑L group in Fig. 2D. A corrected version of Fig. 2 is shown below, featuring the corrected data panels for Fig. 2C and D. Note that the errors in the Figure did not affect either the results or the conclusions reported in this study. The authors are grateful to the Editor of Oncology Letters for granting them the opportunity to publish this corrigendum, and regret any inconvenience caused to the readership of the Journal. [the original article was published in Oncology Letters 15: 3482‑3489, 2018; DOI: 10.3892/ol.2018.7764]

Correction: Corrigendum: IL-17 Promotes Angiogenic Factors IL-6, IL-8, and Vegf Production Via Stat1 in Lung Adenocarcinoma

Correction: Corrigendum: Increased Duodenal Eosinophil Degranulation in Patients with Functional Dyspepsia: A Prospective Study

Correction To: TAOK1 Negatively Regulates IL-17-mediated Signaling and Inflammation

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]

Correction: Corrigendum: Autophagy-associated alpha-arrestin signaling is required for conidiogenous cell development in Magnaporthe oryzae

Correction: Corrigendum: Overexpression of Mirna-497 Inhibits Tumor Angiogenesis by Targeting VEGFR2

Erratum: IL-33 Contributes to Schistosoma Japonicum-Induced Hepatic Pathology Through Induction of M2 Macrophages

Correction to: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma

Corrigendum: Human IL-17 and TNF-α additively or synergistically regulate the expression of proinflammatory genes, coagulation-related genes, and tight junction genes in porcine aortic endothelial cells

Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling: Erratum

[Corrigendum] HIF‑1α Promotes ZEB1 Expression and EMT in a Human Bladder Cancer Lung Metastasis Animal Model

Erratum - MMP-7 is upregulated by COX-2 and promotes proliferation and invasion of lung adenocarcinoma cells.

Correction: Shi, H., et al. Arctigenin Attenuates Breast Cancer Progression through Decreasing GM-CSF/TSLP/STAT3/β-Catenin Signaling. Int. J. Mol. Sci. 2020, 21, 6357

Correction: Corrigendum: Inhibitory Receptors Bind ANGPTLs and Support Blood Stem Cells and Leukaemia Development

[Corrigendum] Role of cysteine‐rich angiogenic inducer 61 in fibroblast‐like synovial cell proliferation and invasion in rheumatoid arthritis

Correction: Chen et al. Heteronemin Suppresses Lymphangiogenesis Through ARF-1 and MMP-9/VE-Cadherin/Vimentin. Biomedicines 2021, 9, 1109

Corrigendum: Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma

Erratum: Cancer-associated Fibroblast-derived IL-6 Promotes Head and Neck Cancer Progression via the Osteopontin-NF-kappa B Signaling Pathway: Erratum.

Correction: YAP Suppresses Lung Squamous Cell Carcinoma Progression Via Deregulation of the DNp63–GPX2 Axis and ROS Accumulation

[Corrigendum] High Expression of RELM-α Correlates with Poor Prognosis and Promotes Angiogenesis in Gastric Cancer

Corrigendum: Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma